Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations

Detalles Bibliográficos
Autores principales: Issa, Amalia M., Thorogood, Adrian, Joly, Yann, Knoppers, Bartha M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608196/
https://www.ncbi.nlm.nih.gov/pubmed/30177852
http://dx.doi.org/10.1038/s41436-018-0264-5
_version_ 1783604784643702784
author Issa, Amalia M.
Thorogood, Adrian
Joly, Yann
Knoppers, Bartha M.
author_facet Issa, Amalia M.
Thorogood, Adrian
Joly, Yann
Knoppers, Bartha M.
author_sort Issa, Amalia M.
collection PubMed
description
format Online
Article
Text
id pubmed-7608196
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-76081962020-11-05 Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations Issa, Amalia M. Thorogood, Adrian Joly, Yann Knoppers, Bartha M. Genet Med Correction Nature Publishing Group US 2018-09-04 2019 /pmc/articles/PMC7608196/ /pubmed/30177852 http://dx.doi.org/10.1038/s41436-018-0264-5 Text en © American College of Medical Genetics and Genomics 2018 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correction
Issa, Amalia M.
Thorogood, Adrian
Joly, Yann
Knoppers, Bartha M.
Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
title Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
title_full Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
title_fullStr Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
title_full_unstemmed Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
title_short Correction to: Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
title_sort correction to: accelerating evidence gathering and approval of precision medicine therapies: the fda takes aim at rare mutations
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608196/
https://www.ncbi.nlm.nih.gov/pubmed/30177852
http://dx.doi.org/10.1038/s41436-018-0264-5
work_keys_str_mv AT issaamaliam correctiontoacceleratingevidencegatheringandapprovalofprecisionmedicinetherapiesthefdatakesaimatraremutations
AT thorogoodadrian correctiontoacceleratingevidencegatheringandapprovalofprecisionmedicinetherapiesthefdatakesaimatraremutations
AT jolyyann correctiontoacceleratingevidencegatheringandapprovalofprecisionmedicinetherapiesthefdatakesaimatraremutations
AT knoppersbartham correctiontoacceleratingevidencegatheringandapprovalofprecisionmedicinetherapiesthefdatakesaimatraremutations

Ejemplares similares